Related Experiment Video

Updated: Aug 29, 2026

Application of Dixon's Up-and-Down Design to Estimate the Minimum Alveolar Concentration of Sevoflurane in Rats with Refined Movement Classification
03:02

Application of Dixon's Up-and-Down Design to Estimate the Minimum Alveolar Concentration of Sevoflurane in Rats with Refined Movement Classification

Published on: July 25, 2025

Single-dose dexmedetomidine reduces agitation after sevoflurane anesthesia in children

Mauricio E Ibacache1, Hernán R Muñoz, Verena Brandes

  • 1From the Departamento de Anestesiología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.

Anesthesia and Analgesia
|December 25, 2003
PubMed

Insights

Dexmedetomidine effectively reduces emergence agitation in children after sevoflurane anesthesia. A 0.3 mcg/kg dose significantly lowered agitation incidence without adverse effects, improving recovery.

Area of Science:

  • Anesthesiology
  • Pediatric Surgery
  • Pharmacology

Background:

  • Emergence agitation is a frequent complication following sevoflurane anesthesia in pediatric patients.
  • Dexmedetomidine, known for its sedative and analgesic properties, presents a potential therapeutic option for managing this side effect.

Purpose of the Study:

  • To evaluate the efficacy of dexmedetomidine in mitigating emergence agitation in children anesthetized with sevoflurane.
  • To assess the impact of different dexmedetomidine dosages on recovery characteristics.

Main Methods:

  • A randomized study involving 90 children (1-10 years) undergoing superficial abdominal/genital surgery.
  • Patients received sevoflurane induction, followed by random assignment to saline, dexmedetomidine 0.15 mcg/kg, or dexmedetomidine 0.3 mcg/kg.
  • Anesthesia was maintained with sevoflurane and nitrous oxide; emergence characteristics and agitation incidence were recorded.

Main Results:

  • The incidence of emergence agitation was significantly lower in the group receiving dexmedetomidine 0.3 mcg/kg (10%) compared to the control group (37%).
  • No significant differences were observed in the time to eye opening or postanesthesia care unit discharge times across groups.
  • No adverse effects were attributed to dexmedetomidine administration.

Conclusions:

  • Dexmedetomidine at a dose of 0.3 mcg/kg is effective in reducing sevoflurane-induced emergence agitation in children.
  • This dosage appears safe and does not negatively impact key recovery parameters like time to discharge.
Abstract

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...